Private company

올리패스

올리패스 is a South Korean company.1 Its revenue was ₩816 million in 2025.1

올리패스 주식회사(OliPass)는 대한민국의 리보핵산(RNA) 치료제 플랫폼 기업이다.2 From the Korean Wikipedia, CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

Revenue over time

As stated on Wikidata, in the currency reported.

Revenue

  • 2025816.0M KRW1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2